Our money or your life : indemnities vs. deductibles in health insurance
When the value of a medical treatment differs across individuals, it may be socially beneficial to treat some, but not all, patients. If individuals are ignorant of their health status ex ante, they should be willing to purchase insurance fully covering treatments for high-benefit patients (Hs) and denying treatment for low-benefit patients (Ls). But if prognoses are observable but not verifiable, insurers may have trouble denying care to Ls. Deductibles force Ls to reveal their status by imposing a marginal cost on treatment, but at a price of incomplete risk-sharing. Lump-sum indemnities can similarly induce Ls to forgo treatment but are rare in health insurance markets. They were once more common and remain so in non-health markets. This paper reviews the potential for health insurance indemnities. We model an insurance market for a single illness and derive conditions determining the relative efficiency of indemnities and deductibles. ; We define a disease that strikes randomly, where there is no private information, and where benefits are measured as cure rates. These and other assumptions yield several rules of thumb: It is never socially or (ex ante) privately beneficial to offer an indemnity larger than the cost of treatment. The optimal indemnity is always larger than the optimal deductible. If Ls outnumber Hs, the best deductible contract always yields higher welfare than the best indemnity contract. As the Ls' cure rate approaches 0, the choice of indemnity or deductible depends entirely upon the relative numbers of Hs and Ls.
|Date of creation:||2000|
|Contact details of provider:|| Web page: http://www.richmondfed.org/|
More information through EDIRC
|Order Information:|| Web: http://www.richmondfed.org/publications/ Email: |
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Bond, Eric W. & Crocker, Keith J., 1997.
"Hardball and the soft touch: The economics of optimal insurance contracts with costly state verification and endogenous monitoring costs,"
Journal of Public Economics,
Elsevier, vol. 63(2), pages 239-264, January.
- Bond, E.W. & Crocker, K.J., 1993. "Hardball and the Soft Touch: The Economics of Optimal Insurance Contracts with Costly State Verification and Endogenous Monitoring Costs," Papers 10-93-1b, Pennsylvania State - Department of Economics.
- Manning, Willard G, et al, 1987. "Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment," American Economic Review, American Economic Association, vol. 77(3), pages 251-277, June.
- Goddeeris, John H, 1984. "Medical Insurance, Technological Change, and Welfare," Economic Inquiry, Western Economic Association International, vol. 22(1), pages 56-67, January.
- Feldstein, Martin S, 1973. "The Welfare Loss of Excess Health Insurance," Journal of Political Economy, University of Chicago Press, vol. 81(2), pages 251-280, Part I, M.
- David M. Cutler & Louise Sheiner, 1998. "Managed Care and the Growth of Medical Expenditures," NBER Chapters,in: Frontiers in Health Policy Research, Volume 1, pages 77-116 National Bureau of Economic Research, Inc.
- David M. Cutler & Louise Sheiner, 1997. "Managed Care and the Growth of Medical Expenditures," NBER Working Papers 6140, National Bureau of Economic Research, Inc.
- Ellis, Randall P. & McGuire, Thomas G., 1990. "Optimal payment systems for health services," Journal of Health Economics, Elsevier, vol. 9(4), pages 375-396, December.
- Hanemann, W Michael, 1991. "Willingness to Pay and Willingness to Accept: How Much Can They Differ?," American Economic Review, American Economic Association, vol. 81(3), pages 635-647, June.
- Fuchs, Victor R & Zeckhauser, Richard, 1987. "Valuing Health--A "Priceless' Commodity," American Economic Review, American Economic Association, vol. 77(2), pages 263-268, May.
- Gianfrancesco, Frank D., 1983. "A proposal for improving the efficiency of medical insurance," Journal of Health Economics, Elsevier, vol. 2(2), pages 175-184, August.
- Richard Arnott & Joseph Stiglitz, 1991. "Equilibrium in Competitive Insurance Markets with Moral Hazard," NBER Working Papers 3588, National Bureau of Economic Research, Inc. Full references (including those not matched with items on IDEAS)